Soliqua 100/33 pen: Dosage, side effects, uses, and more

Managing type 2 diabetes can feel like juggling flaming bowling pins while someone in the background yells, “Don’t forget breakfast!” That is exactly why combination medicines like the Soliqua 100/33 pen get so much attention. Instead of asking one drug to do all the heavy lifting, Soliqua pairs two familiar diabetes treatments in a single prefilled pen: insulin glargine and lixisenatide. The result is a once-daily injection designed to help adults with type 2 diabetes improve blood sugar control along with diet and exercise.

But let’s be honest: when a medicine comes in a pen, people usually want the same practical answers. What is it for? How much do you take? What happens if you miss a dose? What side effects are common, and which ones mean you should stop playing guessing games and call your doctor? This guide walks through the big stuff in plain American English, with the goal of making Soliqua easier to understand without turning the article into a medical dictionary wearing a necktie.

What the Soliqua 100/33 Pen Is and How It Works

Soliqua 100/33 is a prescription injection for adults with type 2 diabetes. It combines two medicines in one SoloStar pen: insulin glargine, a long-acting insulin, and lixisenatide, a GLP-1 receptor agonist. In simple terms, insulin glargine helps provide steady background insulin through the day, while lixisenatide helps the body release insulin when blood sugar rises, slows stomach emptying, and supports better after-meal glucose control.

That two-part approach is what makes Soliqua interesting. It is not just “more insulin,” and it is not simply a GLP-1 medicine wearing an insulin costume. It is a combination product meant to target blood sugar from more than one angle. For adults whose glucose levels are still running high on diabetes pills, basal insulin, or another injectable plan, that can be useful.

Soliqua is not a treatment for type 1 diabetes. It is also not recommended for diabetic ketoacidosis, should not be combined with another GLP-1 receptor agonist, and has not been studied with prandial, or mealtime, insulin. It is also not established as safe and effective for children.

What Is Soliqua 100/33 Used For?

The main use of Soliqua 100/33 is straightforward: it is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. That means it is meant to be part of a full diabetes plan, not a solo superhero. Meal planning still matters. Activity still matters. Blood sugar monitoring still matters. The pen is a tool, not a permission slip to ignore the rest of the routine.

In clinical studies, Soliqua improved A1C in adults whose diabetes was not adequately controlled on oral medications or basal insulin. For many adults with diabetes, an A1C goal around 7% or lower is common, although targets are individualized based on age, overall health, risk of hypoglycemia, and other medical factors. Translation: your neighbor’s glucose goal is not automatically your glucose goal.

Soliqua 100/33 Dosage Basics

When to take it

Soliqua is injected once daily within 1 hour before the first meal of the day. This timing matters. It is not a whenever-you-remember medication. If your mornings are chaotic, it helps to connect the dose to a consistent habit, such as making coffee, setting out breakfast, or staring at your toaster with determination.

Starting dose

The starting dose depends on what diabetes treatment a person was using before Soliqua:

• 15 units once daily is the typical starting dose for adults who are new to basal insulin, new to a GLP-1 receptor agonist, currently taking a GLP-1 receptor agonist, or taking less than 30 units of basal insulin per day.
• 30 units once daily is the typical starting dose for adults currently taking 30 to 60 units of basal insulin per day, with or without a GLP-1 receptor agonist.

Each unit dialed on the pen contains 1 unit of insulin glargine and 0.33 mcg of lixisenatide. The pen is designed for 15 to 60 units per injection, and the maximum daily dose is 60 units.

How dose adjustments usually work

Soliqua is not typically a “set it and forget it” medication. After the starting dose, healthcare providers commonly adjust it based on fasting blood sugar results, glucose trends, and treatment goals. The prescribing information recommends titrating the dose up or down by 2 to 4 units weekly until the desired fasting glucose target is reached.

The important thing here is that you should not freestyle your dose because yesterday’s dessert was ambitious. Any dose change should follow the plan given by your prescriber.

What if you miss a dose?

If you miss a dose of Soliqua, take your next scheduled dose at the regular time the next day. Do not take an extra dose and do not increase your dose to make up for the missed one. Doubling up is not a clever shortcut; it is a fast way to increase risk.

How to Use the Soliqua Pen Correctly

Soliqua is injected under the skin, not into a vein, not into a muscle, and not through an insulin pump. Common injection areas include the abdomen, thigh, and upper arm. Rotate injection sites within the same general region to reduce the risk of skin problems such as thickening, pits, or lumps.

• Always check the label before injecting so you are using the correct pen.
• Only use the medicine if it looks clear and colorless to almost colorless.
• Use a new sterile needle each time.
• Never share the pen, even if the needle has been changed.
• Do not dilute or mix Soliqua with other insulin or medicines.
• Do not remove the medication from the pen with a syringe.

If you are new to injection pens, the best first step is still old-fashioned: ask your healthcare provider or pharmacist to physically show you how to use it. Printed instructions are helpful, but a live demo can save a lot of “Wait, am I holding this upside down?” energy.

Common Side Effects of Soliqua 100/33

Like many diabetes medicines, Soliqua comes with side effects that range from mildly annoying to definitely-call-your-doctor. The most common side effects reported with Soliqua include:

• Low blood sugar (hypoglycemia)
• Nausea
• Stuffy or runny nose and sore throat
• Diarrhea
• Upper respiratory tract infection
• Headache

Gastrointestinal side effects often show up early, especially when a person is just starting the medicine or moving to a higher dose. Nausea is a usual suspect. Diarrhea can also happen. For many people, these issues ease with time, but persistent symptoms should not be ignored. Your stomach is allowed to complain; it just should not file a full legal brief every day.

Hypoglycemia deserves special attention because insulin is part of the medication. Low blood sugar can cause shakiness, sweating, hunger, headache, weakness, confusion, trouble concentrating, or blurred vision. Severe hypoglycemia can be dangerous and may require urgent help.

Serious Side Effects and Safety Warnings

Some side effects are uncommon but important enough to move out of the “watch and wait” category.

Pancreatitis

Soliqua carries a warning for acute pancreatitis. Contact a healthcare professional right away if you develop persistent severe upper abdominal pain, especially if it comes with vomiting or seems to radiate into the back.

Serious allergic reactions

Anaphylaxis and other serious hypersensitivity reactions can happen. Emergency care is needed for trouble breathing, swelling of the face or throat, widespread rash, or symptoms of a severe allergic reaction.

Kidney problems from dehydration

Nausea, vomiting, and diarrhea can lead to dehydration, which may contribute to acute kidney injury. This matters even more for people who already have kidney disease. If GI symptoms are severe or do not let up, contact your prescriber promptly.

Severe gastrointestinal problems

Because lixisenatide slows stomach emptying, Soliqua is not recommended for people with severe gastroparesis. If food already lingers in your stomach like it forgot its car keys, this medicine may not be the right fit.

Gallbladder disease

New or worsening upper abdominal pain, fever, yellowing of the skin or eyes, or pale stools can be warning signs that need prompt medical attention.

Surgery and anesthesia warning

Soliqua can delay gastric emptying, and the prescribing information includes a warning about rare cases of pulmonary aspiration during procedures involving general anesthesia or deep sedation. Always tell your surgical team and anesthesia team that you are taking Soliqua before a planned procedure.

Drug Interactions and Practical Timing Rules

One of the sneakiest things about Soliqua is that it can affect how some oral medicines are absorbed. That is because the lixisenatide component slows stomach emptying.

• Antibiotics and acetaminophen: these should generally be taken at least 1 hour before your Soliqua injection. If they must be taken later, follow your clinician’s instructions.
• Oral contraceptives: birth control pills should be taken at least 1 hour before Soliqua or at least 11 hours after the injection.

Other medicines can also affect blood sugar, including corticosteroids, some diuretics, estrogens, thyroid hormones, and certain psychiatric medications. Beta-blockers may make symptoms of low blood sugar harder to notice. If you take a thiazolidinedione such as pioglitazone, your clinician may also watch for fluid retention or worsening heart failure when it is used with insulin-based therapy.

Storage: The Not-So-Glamorous But Very Important Part

Storage rules are not exciting, but they do matter. A medication that is stored incorrectly can stop acting like itself, and that is not something you want from a diabetes medicine.

• Store new, unused pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
• Do not freeze the pen. If it freezes, throw it away.
• After first use, store the pen at room temperature up to 77°F (25°C).
• Do not put the pen back in the refrigerator after first use.
• Do not store the pen with the needle attached.
• Use the pen for up to 28 days after first use, then discard it even if medication remains.

Also, dispose of used needles and pens in an appropriate sharps container. Your kitchen junk drawer is not a sharps program, no matter how optimistic it feels.

Who Should Ask Extra Questions Before Starting Soliqua?

Soliqua may require extra caution or a different treatment discussion if you:

• have frequent low blood sugar episodes
• have kidney disease or severe dehydration risk
• have severe gastroparesis or significant digestive motility problems
• have a history of pancreatitis or gallbladder issues
• are pregnant, planning pregnancy, or breastfeeding
• take oral contraceptives, antibiotics, or medicines with timing-sensitive absorption
• take medicines that may raise, lower, or mask blood sugar changes
• have visual impairment and rely on pen clicks rather than the dose window

None of that means Soliqua is automatically off the table. It just means the prescribing decision should be thoughtful, not rushed.

Real-World Experience: What Using the Soliqua 100/33 Pen Often Feels Like

In everyday life, the experience of using Soliqua usually has less to do with the chemistry lesson and more to do with routine. Many adults find that the first real challenge is not the injection itself. It is remembering that Soliqua has a schedule: once a day, within an hour before the first meal. For people who already have a predictable breakfast, that timing can feel manageable. For people whose morning plan changes every day, the medicine can force a little structure into the day. Sometimes that is helpful. Sometimes it feels like your calendar and your pancreas are suddenly in a committed relationship.

The first few weeks are often the adjustment phase. Some people feel relieved because one pen replaces a more complicated setup. Others notice mild nausea, reduced appetite, or a general sense that their stomach is moving a little more slowly than usual. That does not mean the medicine is “bad,” but it does mean the body notices the lixisenatide component. Small meals, steady hydration, and patience often become part of the early routine. A giant greasy breakfast right after an injection is usually not the move if your stomach is already trying to renegotiate the contract.

Another common day-to-day experience is becoming more aware of blood sugar patterns. Because Soliqua includes insulin, people may pay closer attention to fasting readings, meal timing, and symptoms of hypoglycemia. Some describe a learning curve where they start connecting real-life moments to glucose changes: skipping breakfast, exercising harder than usual, sleeping late on a weekend, or eating dinner much later than normal. The medicine works best when people do not treat those details like background noise.

The pen itself is often seen as easier than many first-time users expect. Once someone is shown how to attach a needle, dial the dose, inject, and rotate sites, the process can become quick and mechanical. Still, practical annoyances pop up. People forget to bring the pen when they travel. They realize too late that they need extra pen needles. They wonder whether the pen has been at room temperature too long. They question whether they actually took the dose or only thought about taking the dose while making toast. In other words, the “experience” of Soliqua is usually less dramatic than the internet makes it sound, but more detailed than the package photo suggests.

Over time, many people say the biggest shift is confidence. The injection feels less intimidating. Timing becomes more automatic. They learn what side effects are mild and temporary, and which symptoms deserve a call to the clinic. They get used to reading the dose window, rotating sites, and keeping the pen stored properly. That is often the real story with Soliqua: not a miracle, not a disaster, just a medicine that tends to work best when the user builds a reliable routine around it. The pen may be small, but the habit around it is doing a lot of the heavy lifting.

Final Takeaway

The Soliqua 100/33 pen is a once-daily combination treatment for adults with type 2 diabetes that brings together long-acting insulin and a GLP-1 receptor agonist in one device. Its biggest strengths are convenience, clear dosing ranges, and a dual-action approach to blood sugar control. Its biggest watch-outs are also clear: low blood sugar, nausea, GI effects, dosing mistakes, dehydration, and important timing issues with some oral medicines.

For the right person, Soliqua can be a practical, effective part of a broader diabetes plan. The key is using it exactly as prescribed, monitoring blood sugar carefully, and treating side effects and warning signs with appropriate respect. In other words, this is not a casual pen. It is a serious diabetes tool that rewards consistency and punishes improvisation.

Conclusion

If you are comparing treatment options or trying to understand why your clinician recommended Soliqua 100/33, the short version is this: it is built for adults with type 2 diabetes who may need stronger glucose control without juggling separate injections for basal insulin and a GLP-1 drug. The dosing rules are specific, the storage rules matter, and the side-effect profile is manageable for many people when they know what to expect. Learn the timing, respect the maximum dose, pay attention to low blood sugar and stomach symptoms, and keep your prescriber in the loop. That is the practical path to using Soliqua wisely.